Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-Based Vaccine Candidates Against SARS-COV-2

Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?